FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

27957011000001101: Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Nov 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
87537301000001116 Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
106876601000001114 Ziclaseg 30mg modified-release tablets (Lupin Healthcare (UK) Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) Is a Gliclazide 30mg modified-release tablets true Inferred relationship Existential restriction modifier
Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) Is a Gliclazide 30mg m/r tablet false Inferred relationship Existential restriction modifier
Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) Has active ingredient Gliclazide true Inferred relationship Existential restriction modifier
Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) Has specific active ingredient Gliclazide true Inferred relationship Existential restriction modifier
Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) Is a Ziclaseg true Inferred relationship Existential restriction modifier
Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) Is a Gliclazide 30mg modified-release tablets false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) 28 tablet Has AMP True Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) Inferred relationship Existential restriction modifier
Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) 56 tablet Has AMP True Ziclaseg 30mg modified-release tablets (Lupin (Europe) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start